Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109
In the published publication [...]
Main Authors: | Albert Yu, Xiaoyong Dai, Zixian Wang, Huaqing Chen, Bing Guo, Laiqiang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Biosensors |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6374/12/10/794 |
Similar Items
-
Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy
by: Albert Yu, et al.
Published: (2022-02-01) -
<i>Biosensors</i> in 2022
by: Giovanna Marrazza
Published: (2023-03-01) -
Acknowledgment to the Reviewers of <i>Biosensors</i> in 2022
by: Biosensors Editorial Office
Published: (2023-01-01) -
In Vivo Efficacy of SQ109 against <i>Leishmania donovani</i>, <i>Trypanosoma</i> spp. and <i>Toxoplasma gondii</i> and In Vitro Activity of SQ109 Metabolites
by: Kyung-Hwa Baek, et al.
Published: (2022-03-01) -
Mesoporous silica/organosilica nanoparticles for cancer immunotherapy
by: Shevanuja Theivendran, et al.
Published: (2023-06-01)